Vertex Pharmaceuticals, Inc. (VRTX) Misses Q2 EPS by 13c; Revises Revenues
Go back to Vertex Pharmaceuticals, Inc. (VRTX) Misses Q2 EPS by 13c; Revises Revenues| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 516.44 -9.29 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $525.73 | 52 Week High | $134.71 | |||
| Open | $528.68 | 52 Week Low | $73.31 | |||
| Day High | $529.00 | P/E | N/A | |||
| Day Low | $515.74 | EPS | $-1.98 | |||
| Volume | 863,493 | |||||
